Melnite

Melatonin, the active ingredient in Melnite, is a melatonin receptor agonist presented as an oral formulation for oral use. It mimics the endogenous hormone that signals darkness to the brain, thereby helping to synchronize circadian rhythms and improve sleep onset, duration, and quality in adults experiencing insomnia or jet‑lag related disturbances.

GNH USA supplies Melnite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and provides regulatory‑compliant shipments to a global network of healthcare providers.

Melnite (melatonin) acts on the melatonin receptor pathway to address disorders of the sleep‑wake cycle.

Insomnia: reduces sleep onset latency and improves total sleep time in adults. Delayed sleep phase disorder: advances circadian timing to promote earlier sleep onset. Jet lag: alleviates sleep disruption and daytime fatigue after rapid time‑zone travel.

Oral melatonin may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Headache: mild to moderate pain in the head. - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives requiring medical attention. - Mood changes: depression, irritability, or anxiety that are severe. - Severe hypotension: marked drop in blood pressure leading to faintness.

When considering melatonin therapy, several safety considerations should be reviewed.

Pregnancy: safety has not been established; use only if potential benefit justifies the risk. Breastfeeding: unknown effects on infant; discuss with healthcare professional. Concomitant CNS depressants: may enhance sedative effects, requiring monitoring. Autoimmune disorders: melatonin can modulate immune function; observe for disease activity changes. Store at ambient temperature: keep in original container, protect from moisture and light.

Melatonin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce melatonin clearance.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): additive sedation. - Antidepressants (e.g., SSRIs): possible serotonin syndrome. - Oral contraceptives: may increase melatonin plasma levels.